| Adipose tissue–derived human mesenchymal stem cells mediated prodrug cancer gene therapy L Kucerova, V Altanerova, M Matuskova, S Tyciakova, C Altaner Cancer research 67 (13), 6304-6313, 2007 | 517 | 2007 |
| Multilineage cells from adipose tissue as gene delivery vehicles K Morizono, DA De Ugarte, M Zhu, P Zuk, A Elbarbary, P Ashjian, ... Human gene therapy 14 (1), 59-66, 2003 | 246 | 2003 |
| Tumor cell behaviour modulation by mesenchymal stromal cells L Kucerova, M Matuskova, K Hlubinova, V Altanerova, C Altaner Molecular cancer 9, 1-15, 2010 | 241 | 2010 |
| Adipose tissue–derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth IT Cavarretta, V Altanerova, M Matuskova, L Kucerova, Z Culig, C Altaner Molecular Therapy 18 (1), 223-231, 2010 | 223 | 2010 |
| Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice L Kucerova, M Matuskova, A Pastorakova, S Tyciakova, J Jakubikova, ... The Journal of Gene Medicine: A cross‐disciplinary journal for research on …, 2008 | 208 | 2008 |
| HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells M Matuskova, K Hlubinova, A Pastorakova, L Hunakova, V Altanerova, ... Cancer letters 290 (1), 58-67, 2010 | 196 | 2010 |
| Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer J Plava, M Cihova, M Burikova, M Matuskova, L Kucerova, S Miklikova Molecular cancer 18, 1-10, 2019 | 162 | 2019 |
| Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells L Kucerova, S Skolekova, M Matuskova, M Bohac, Z Kozovska BMC cancer 13, 1-13, 2013 | 108 | 2013 |
| Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells S Skolekova, M Matuskova, M Bohac, L Toro, E Durinikova, S Tyciakova, ... Cell Communication and Signaling 14, 1-13, 2016 | 93 | 2016 |
| ALDH1A inhibition sensitizes colon cancer cells to chemotherapy Z Kozovska, A Patsalias, V Bajzik, E Durinikova, L Demkova, S Jargasova, ... BMC cancer 18 (1), 1-11, 2018 | 67 | 2018 |
| Type 3 inositol 1, 4, 5-trisphosphate receptor has antiapoptotic and proliferative role in cancer cells I Rezuchova, S Hudecova, A Soltysova, M Matuskova, E Durinikova, ... Cell death & disease 10 (3), 186, 2019 | 64 | 2019 |
| Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells L Kucerova, M Kovacovicova, S Polak, M Bohac, J Fedeles, D Palencar, ... Neoplasma 58 (5), 361, 2011 | 58 | 2011 |
| Therapeutic Dendritic Cell− Based Cancer Vaccines: The State of the Art MM Strioga, T Felzmann, DJ Powell Jr, V Ostapenko, NT Dobrovolskiene, ... Critical Reviews™ in Immunology 33 (6), 2013 | 55 | 2013 |
| Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model L Kucerova, S Skolekova, L Demkova, R Bohovic, M Matuskova Gene therapy 21 (10), 874-887, 2014 | 48 | 2014 |
| ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells E Durinikova, Z Kozovska, M Poturnajova, J Plava, Z Cierna, A Babelova, ... BMC cancer 18, 1-15, 2018 | 47 | 2018 |
| Molecular features and gene expression signature of metastatic colorectal cancer M Poturnajova, T Furielova, S Balintova, S Schmidtova, L Kucerova, ... Oncology Reports 45 (4), 1-1, 2021 | 46 | 2021 |
| Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases M Matuskova, Z Kozovska, L Toro, E Durinikova, S Tyciakova, Z Cierna, ... Journal of Experimental & Clinical Cancer Research 34, 1-11, 2015 | 42 | 2015 |
| Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft S Tyciakova, M Matuskova, R Bohovic, K Polakova, L Toro, S Skolekova, ... The Journal of Gene Medicine 17 (1-2), 54-67, 2015 | 42 | 2015 |
| Aldehyde dehydrogenase 1A1 and 1A3 isoforms–mechanism of activation and regulation in cancer M Poturnajova, Z Kozovska, M Matuskova Cellular Signalling 87, 110120, 2021 | 40 | 2021 |
| Disulfiram overcomes cisplatin resistance in human embryonal carcinoma cells S Schmidtova, K Kalavska, K Gercakova, Z Cierna, S Miklikova, ... Cancers 11 (9), 1224, 2019 | 38 | 2019 |
